10/22/2025
Long COVID affects millions, with symptoms like fatigue, brain fog, and breathlessness lasting months post-infection. About 15% still experience symptoms a year later, driving urgent demand for effective treatments.
Niagen Bioscience co-funded a randomized, double-blind, placebo-controlled trial to evaluate NR (nicotinamide riboside) supplementation’s impact on NAD+ levels and long COVID symptoms.
Join us Tuesday, November 4 at 1 PM ET for "At the Crossroads of NAD+ and Long COVID - Emerging Data on Nutrition Interventions," a webinar sponsored by Niagen Bioscience, Inc.
Register at: discover.nutrition.org/content/sponsored-webinar-crossroads-nad-and-long-covid-emerging-data-nutrition-interventions
Can't attend live? Register to receive the recording after the session.